Director Shareholding
March 18 2002 - 10:42AM
UK Regulatory
RNS Number:1534T
Cambridge Antibody Tech Group PLC
18 March 2002
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
David Chiswell
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 above
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Exercise of 166,116 share options and sale of 85,702 shares of that 166,116
shares granted under the Executive Scheme and Company Share Option Plan.
7) Number of shares/amount of
stock acquired
166,116
8) Percentage of issued class
0.47%
9) Number of shares/amount
of stock disposed
85,702
10) Percentage of issued class
0.24%
11) Class of security
Ordinary 10p shares
12) Price per share
£15.40
13) Date of transaction
15 March 2002
14) Date company informed
15 March 2002
15) Total holding following this notification
522,396
16) Total percentage holding of issued class following this notification
1.47%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 18 March 2002
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
Peter Garland
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
(i) Peter Garland
(ii) Ann Garland
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
a) Peter Garland
b) Ann Garland
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
(i) As in 2 above
(ii) Spouse
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
(i) Transfer of 1,375 shares to adult child.
(ii) Transfer of 1,375 shares to adult child.
7) Number of shares/amount of
stock acquired
Nil
8) Percentage of issued class
Nil
9) Number of shares/amount
of stock disposed
(i) 1,375
(ii) 1,375
10) Percentage of issued class
(i) 0.004%
(ii) 0.004%
11) Class of security
Ordinary 10p shares
12) Price per share
13) Date of transaction
15 March 2002
14) Date company informed
15 March 2002
15) Total holding following this notification
39,075
16) Total percentage holding of issued class following this notification
0.11%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 18 March 2002
This information is provided by RNS
The company news service from the London Stock Exchange
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024
